Molecule intelOpportunity: Moderate0Underserved

Bismuth Subcitrate

3 brands · 1 companies · product forms

Opportunity snapshot

Launch attractiveness
48
Market saturation
3
Price room
25
Regulatory risk
0
3
brands
1
companies
Rs 285
median price
3
price points
2x
price spread
90
confidence %

Who competes here

Top companies by brand count · leader share 33%

Price room

Across observed sources and strengths
CheapestRs 142.5
MedianRs 285
Most expensiveRs 285
Spread2×
Sources: DVAGO, Servaid

max/min price ratio 2.00x across 3 trusted points (Rs 142.5-285.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Why this score

Launch attractiveness

40% supply-gap(60) + 25% price-variation(25) + 20% low-competition(97) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

1 canonical companies and 3 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 2.00x across 3 trusted points (Rs 142.5-285.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.